Turn Your Back on Cancer
Turn Your Back on Cancer November 2025 – March 2026 About the “Turn Your Back on Cancer” Campaign The campaign ran from November 2025 to March 2026 and aimed at raising awareness of the possibilities of population-based cancer screening programmes. Communication Strategy A comprehensive communication strategy was implemented to integrate the topic of cancer screening […]
Avoidable Cancer Deaths: a Population-Based Study
Avoidable Deaths Through the Primary Prevention, Early Detection, and Curative Treatment of Cancer Worldwide A Population-Based Study Available Public Health and Clinical Interventions The International Agency for Research on Cancer (IARC) has published new research estimating the global number of cancer deaths that could potentially be avoided through effective prevention measures, earlier diagnosis, and access […]
IARC at the European Cancer Screening and Early Detection Policy Summit in Brussels
IARC at the European Cancer Screening and Early Detection Policy Summit in Brussels European Policymakers and Researchers Discuss Expanding Evidence-based Cancer Screening Programmes European Cancer Screening and Early Detection Policy Summit Scientists from the International Agency for Research (IARC) on Cancer participated in the European Cancer Screening and Early Detection Policy Summit. It held on […]
Prostate cancer Awareness (PRAISE-U)
Prostate cancer Awareness and Initiative for Screening in the European Union (PRAISE-U) PRAISE-U and Prostate Cancer Awareness The ‘PRostate cancer Awareness and Initiative in the EU’ (PRAISE-U) consortium, led by the European Association of Urology (EAU), is dedicated to reducing morbidity and mortality caused by prostate cancer in the EU. This project aims to provide […]
Towards Smarter, More Precise and More Effective Healthcare – Insights from the Conference on Personalised Cancer Screening in Riga, Latvia
Latvia, Riga, 08-10-2025 Towards Smarter, More Precise and More Effective Healthcare – Insights from the Conference on Personalised Cancer Screening in Riga, Latvia Insights from the Conference on Personalised Cancer Screening in Riga, Latvia On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place in Riga, at […]
International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts
Latvia, Riga, 08-10-2025 International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts Personalised Cancer Screening Conference On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place at the University of Latvia in Riga. Organised as part of the EUCanScreen Joint Action, the […]
European Prostate Cancer Awareness Day 2025
Belgium, Brussels, 03.09.2025 European Prostate Cancer Awareness Day 2025 Experts, policy makers, and patient representatives will gather to explore how public policies can dramatically improve screening and early detection. Prostate Cancer Awareness On European Prostate Cancer Awareness Day, experts, policy makers, and patient representatives will gather to explore how public policies can dramatically improve screening and […]
New IARC framework for regional cancer prevention codes
New IARC framework for regional cancer prevention codes Methodology released for developing regional Codes within the World Code Against Cancer Framework Cancer prevention codes IARC published a methodological document to support regions and countries in developing localized “Cancer Codes” within the broader World Code Against Cancer Framework. These codes aim to provide practical, evidence-based, and […]
World Prostate Cancer Day
11.06.2025 World Prostate Cancer Day An opportunity to strengthen awareness Every year, on 11 June, World Prostate Cancer Day is observed to raise public awareness about one of the most prevalent male neoplasms. This day fits within a European context increasingly focused on prevention and early diagnosis—fundamental pillars to improve treatment outcomes and reduce mortality. […]